Lung Research Funding Expands to Support 120 Projects
The American Lung Association is investing $21 million to improve prevention and treatment for patients with lung disease.
Updated on Oct. 30, 2026 in Asthma
Live Poll
Should organizations prioritize funding research for specific lung diseases over general public health initiatives?
The American Lung Association announced a $21 million investment in respiratory research for 2026, supporting 120 projects. This effort is part of a broader decade-long commitment to advancing prevention, diagnosis, and treatment for lung diseases.
Why it matters
Targeted research funding is essential to improve long-term clinical outcomes for the estimated 50 lung diseases affecting millions. This sustained investment seeks to accelerate breakthroughs in areas ranging from lung cancer to respiratory pathogens.
The American Lung Association provided $11 million in direct funding across 120 distinct research projects during 2026. This activity builds on a decade of support totaling $193 million, though the long-term clinical impact of these specific awards is currently being tracked.
The players
American Lung Association
A national health organization focused on the prevention, diagnosis, and treatment of over 50 lung diseases through public health advocacy and research funding.
The details
The funding supports a multifaceted research approach including the Airways Clinical Research Centers Network and the Accelerator Program. Each project undergoes a rigorous peer-review process to ensure scientific merit and potential for public health improvement. Research areas encompass allergic respiratory diseases, interstitial lung disease, indoor air quality, and public policy.
Timeline
2016 to 2026: $193 million total invested in research.
October 29, 2026: $21 million investment announced.
2027-2028: Research awards and grants cycle.
Health Landscape
This investment continues the expansion of the Airways Clinical Research Centers Network as the central hub for respiratory innovation. It highlights a shift toward sustained, multi-year support for diverse lung conditions rather than fragmented, short-term research initiatives.
This research initiative aims to improve diagnostic tools and treatment protocols for those managing chronic respiratory conditions. Patients interested in how these advancements might affect their long-term care plans should discuss current research breakthroughs with their pulmonologist.
The takeaway
Ongoing investment in respiratory science drives essential improvements in the diagnosis and prevention of lung disease. Patients should stay informed on new clinical guidelines or trials that emerge from these national research networks by consulting their regular healthcare provider.
Further reading
Learn more about the latest research and advocacy efforts in the Asthma section.
More information
Researchers and institutions can apply for the upcoming cycle through the 2027-2028 research grant applications portal.
Source note: This article includes information reported by The Beatrice Daily Sun.
Live Poll
Should organizations prioritize funding research for specific lung diseases over general public health initiatives?
